Genexine Inc (095700)

KOSDAQ

Currency in KRW

5,120

+140(+2.81%)

Closed·07:29:59

Fair Value

Unlock Value

Day's Range

4,910

5,200

52 wk Range

3,510

10,230

095700 Financial Summary

A brief financial summary of Genexine Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-3.71

Price/Book0.71

Debt / Equity23.84%

Return on Equity-17.31%

Dividend Yield0.00%

EBITDA-36.90B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Income Statement

Total Revenues

aa.aa

11,303.05

18,543.49

36,828.45

16,139.03

4,426.63

Gross Profit

aa.aa

6,699.23

9,759.36

30,743.38

11,248.13

302.04

Operating Income

aa.aa

-44,573.03

-39,151.37

-19,099.28

-33,679.78

-41,928.45

Net Income

aa.aa

-16,509.2

27,569.72

-48,041.82

-55,973.93

-66,873.52

Balance Sheet

Total Assets

aa.aa

358,176.68

596,907.82

636,864.82

388,781.11

376,586.6

Total Current Liabilities

aa.aa

22,637.59

40,217.27

59,153.81

78,933.22

54,526.28

Total Equity

aa.aa

296,909.42

536,533.11

519,459.14

277,394.49

296,903.62

Cash Flow

Levered Free Cash Flow

aa.aa

-30,297.21

-48,226.93

-96,774.65

-30,285.64

Cash from Operations

aa.aa

-41,571.71

-22,690.96

-12,745.36

-39,799.59

-38,054.51

Cash from Investing

aa.aa

1,636.89

-64,393.95

-7,704.47

-1,915.44

-34,282.64

Cash from Financing

aa.aa

3,328.13

73,358.17

43,086.85

31,632.26

60,426.64

Net Change in Cash

aa.aa

-36,627.21

-13,880.52

22,583.7

-9,853.44

-11,910.21

* In Millions of KRW (except for per share items)

Earnings

Latest Release

May 19, 2025

EPS / Forecast

-- / --

Revenue / Forecast

-- / --

EPS Revisions

Unlock

Last 90 days

FAQ

What was Genexine's net income for the latest quarter?

Genexine's net income for the latest quarter was -11,565.60.

How did Genexine's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,534.60 in the previous quarter to 2,073.22 in the latest quarter, and net income moved from 2,589.67 to -11,565.60 compared to the previous quarter.

What is Genexine's net profit margin on a TTM basis?

Genexine's trailing twelve months (TTM) net profit margin is -1,510.71%.

How does Genexine's debt to equity ratio compare to industry standards?

Genexine's total debt-to-equity ratio is 23.84%.

What is Genexine's return on investment on a TTM basis?

Genexine's trailing twelve months (TTM) return on investment (ROI) is -17.31%.

Did Genexine gain or lose cash last quarter?

In the latest quarter, Genexine's net change in cash was -4,316.65 million.

What were Genexine's total assets and liabilities in the latest quarter?

As of the latest quarter, Genexine reported total assets of 365,386.80 million and total liabilities of 51,787.03 million.

How has Genexine's total revenue grown this year?

Genexine's total revenue was 1,534.60 in the previous quarter and 2,073.22 in the latest quarter.

What was Genexine's revenue per share for the latest quarter?

Genexine's revenue per share for the latest quarter was 1,259.66.

NSE 30

5,139.93

+18.90

+0.37%

NSE All Share

141,004.14

+671.70

+0.48%

US 30

45,707.00

+921.5

+2.06%

US 500

6,471.70

+101.5

+1.59%

FTSE 100

9,321.40

+12.20

+0.13%

DAX

24,370.74

+77.40

+0.32%

South Africa Top 40

95,066.86

+946.46

+1.01%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	11.000	+2.33%	135.96M
Nigerian Breweries	70.00	+2.49%	43.26M
Transcorp Power	286.50	0.00%	29.76M
UBA	47.95	-0.10%	18.97M
Guaranty Trust Holding	94.00	+1.35%	15.99M
STANBIC IBTC Bank	94.00	-0.53%	13.33M
MTN Nigeria	435.00	0.00%	1.79M

Name	Last	Chg. %	Vol.
Betaglas	449.35	+10.00%	539.74K
FTN Cocoa Processors PLC	6.60	+10.00%	2.67M
Veritas Kapital	1.98	+10.00%	18.48M
UPDC	6.93	+10.00%	2.33M
Sovereign Trust Insurance Plc	2.65	+9.96%	19.48M
Ncr Nigeria	10.50	+9.95%	108.10K
Prestige	1.77	+9.94%	22.95M

Name	Last	Chg. %	Vol.
Thomaswy	3.00	-9.91%	1.35M
McNichols	3.20	-7.51%	3.39M
Initiates	12.30	-4.43%	2.23M
Etranz	10.850	-3.98%	481.90K
Npfmcrfbk	3.110	-2.81%	2.11M
Lafarge Africa	134.55	-1.82%	1.68M
Multverse	10.90	-0.91%	654.92K

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	15.50	+0.65%	5.70M
Mutual Benefits Assurance	4.40	+8.91%	28.98M
Jaiz Bank	4.50	+2.51%	13.64M
Veritas Kapital	1.98	+10.00%	18.48M
Guaranty Trust Holding	94.00	+1.35%	15.99M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa Aaa	5,379.30	+50.16%	8,077.56
Aaaa Aa Aaaaaaaaa	520.00	+41.84%	737.57
Aaaa A A Aaaa Aa	1,890.00	+39.62%	2,638.82
Aaaaa Aaaaa Aa	151.80	+36.72%	207.54
Aa Aaaaa Aaa Aaa	70.20	+20.51%	84.60

Name	Last	Upside	Fair Value
Aaaaaaa Aaa	5,379.30	+50.16%	8,077.56
Aaaa Aa Aaaaaaaaa	520.00	+41.84%	737.57
Aaaa A A Aaaa Aa	1,890.00	+39.62%	2,638.82
Aaaaa Aaaaa Aa	151.80	+36.72%	207.54
Aa Aaaaa Aaa Aaa	70.20	+20.51%	84.60

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Genexine Inc (095700)

095700 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What was Genexine's net income for the latest quarter?

How did Genexine's performance compare year-over-year in the latest quarter?

What is Genexine's net profit margin on a TTM basis?

How does Genexine's debt to equity ratio compare to industry standards?

What is Genexine's return on investment on a TTM basis?

Did Genexine gain or lose cash last quarter?

What were Genexine's total assets and liabilities in the latest quarter?

How has Genexine's total revenue grown this year?

What was Genexine's revenue per share for the latest quarter?

Trending Stocks